Aesthetic surgery journal · 2025
Evaluating the Role of Gynecomastia Surgery in Improving Sexual Function and Hormonal Profiles.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Akdağ Tansu, Akdağ Abdullah, Özkan Mustafa, Aydın Osman Enver
Аннотация
BACKGROUND: Patients with gynecomastia may experience hormonal imbalances and sexual dysfunctions, such as erectile and ejaculatory disorders.
OBJECTIVES: This study evaluates the changes in hormonal parameters and sexual function following gynecomastia surgery.
METHODS: Thirty-two male patients (aged 15-65) without systemic or genetic comorbidities underwent gynecomastia surgery. Preoperative and postoperative hormonal parameters free and total testosterone, estrogen (EST), prolactin (PRL), follicle-stimulating hormone, luteinizing hormone, sex hormone-binding globulin, and sexual function scores (International Index of Erectile Function [IIEF], Premature Ejaculation Diagnostic Tool [PEDT]) were assessed. A urologist blinded to the study evaluated patients andrologically.
RESULTS: The mean age of the patients was 25.69 ± 10.37 years. Postoperative PRL and EST levels significantly decreased (P = .03 and P < .001, respectively). All IIEF subscale scores showed significant postoperative improvements (P-values ranging from <.001 to .006). PEDT scores significantly decreased postoperatively (P < .001).
CONCLUSIONS: Surgical treatment of gynecomastia leads to significant improvements in hormonal parameters and sexual function. These benefits should be considered in surgical planning.
OBJECTIVES: This study evaluates the changes in hormonal parameters and sexual function following gynecomastia surgery.
METHODS: Thirty-two male patients (aged 15-65) without systemic or genetic comorbidities underwent gynecomastia surgery. Preoperative and postoperative hormonal parameters free and total testosterone, estrogen (EST), prolactin (PRL), follicle-stimulating hormone, luteinizing hormone, sex hormone-binding globulin, and sexual function scores (International Index of Erectile Function [IIEF], Premature Ejaculation Diagnostic Tool [PEDT]) were assessed. A urologist blinded to the study evaluated patients andrologically.
RESULTS: The mean age of the patients was 25.69 ± 10.37 years. Postoperative PRL and EST levels significantly decreased (P = .03 and P < .001, respectively). All IIEF subscale scores showed significant postoperative improvements (P-values ranging from <.001 to .006). PEDT scores significantly decreased postoperatively (P < .001).
CONCLUSIONS: Surgical treatment of gynecomastia leads to significant improvements in hormonal parameters and sexual function. These benefits should be considered in surgical planning.